21/03/2026
A guideline from the American College of Gastroenterology recommends rifabutin triple therapy or potassium-competitive acid blocker-based regimens for treatment-naive adults with Helicobacterpylori infection unable to receive bismuth quadruple therapy.
https://ja.ma/4sYWwPe